Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/106610
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: ABCB1 Overexpression Is a key initiator of resistance to tyrosine kinase inhibitors in CML cell lines
Author: Eadie, L.
Hughes, T.
White, D.
Citation: PLoS ONE, 2016; 11(8):e0161470-1-e0161470-18
Publisher: Public Library Science
Issue Date: 2016
ISSN: 1932-6203
1932-6203
Statement of
Responsibility: 
Laura N. Eadie, Timothy P. Hughes, Deborah L. White
Abstract: The tyrosine kinase inhibitor (TKI) imatinib has resulted in excellent responses in the majority of Chronic Myeloid Leukaemia (CML) patients; however, resistance is observed in 20-30% of patients. More recently, resistance to the second generation TKIs, nilotinib and dasatinib, has also been observed albeit at a lower incidence. ABCB1 has previously been implicated in TKI export and its overexpression linked to TKI resistance. In this study the dynamics of nilotinib resistance was studied in CML cell lines with particular focus on ABCB1 expression levels during development of resistance. Results revealed ABCB1 overexpression is likely an important initiator of nilotinib resistance in vitro. ABCB1 overexpression was also observed in cell lines as an intermediate step during development of resistance to imatinib and dasatinib in vitro. We conclude that ABCB1 overexpression may provide an initial platform to facilitate development of additional mechanisms for resistance to TKIs. This provides a rationale for investigating this phenomenon in patients undergoing TKI therapy.
Keywords: Gene expression; protein expression; cell staining; hyperexpression techniques; kinase inhibitors; tyrosine kinase inhibitors; cell viability testing; tyrosine kinases
Rights: © 2016 Eadie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
RMID: 0030053807
DOI: 10.1371/journal.pone.0161470
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_106610.pdfPublished version4.82 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.